CalciMedica Inc. (CALC)
(Delayed Data from NSDQ)
$4.08 USD
+0.12 (3.04%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $4.14 +0.06 (1.47%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CALC 4.08 +0.12(3.04%)
Will CALC be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for CALC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CALC
Strength in Kidney Care Likely to Aid DaVita's (DVA) Q2 Earnings
Does CalciMedica Inc. (CALC) Have the Potential to Rally 232.3% as Wall Street Analysts Expect?
CALC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?
Other News for CALC
CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Standard BioTools And 2 Other Penny Stocks Executives Are Buying
CalciMedica Shareholders Back Expansion and Elect Directors
Director Robert Wilson Acquires 54,000 Shares of CalciMedica Inc (CALC)
CalciMedica director buys $201K in common stock